CXCR2 inhibition enables NASH-HCC immunotherapy. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/gutjnl-2021-326259

PubMed Identifier: 35477863

Publication URI: http://europepmc.org/abstract/MED/35477863

Type: Journal Article/Review

Volume: 71

Parent Publication: Gut

Issue: 10

ISSN: 0017-5749